Medicine
Xcopri 100 mg tablet
Xcopri 100 mg tablet is a prescription medicine containing Cenobamate for oral use, marketed by SK Life Science, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store XCOPRI tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted…
Key facts
- Active ingredient (INN)
- Cenobamate
- Brand
- Xcopri
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- SK Life Science
- Manufacturer
- SK Life Science
- Origin register
- US FDA, United States
- Storage
- Store XCOPRI tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CV
- ATC code
- N03AX Anticonvulsant agent, subgroup N03AX
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 March 2020
- Identifiers
- RxCUI 2265695, 2265701, 2283503 +7DailyMed set ID 565c2126-57ae-4e29-b443-723bbe7e2072NDC 71699-100Application NDA212839
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 71699-100-30 | SK Life Science | 12 March 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cenobamate
Clinical summary
Cenobamate is a prescription medicine indicated for the treatment of partial-onset seizures in adult patients. It is available as tablets and kits for oral use. MedsAcross supplies Cenobamate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CenobamateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xcopri prescribing information (SK Life Science) · U.S. National Library of Medicine, DailyMed
- Ontozry: European public assessment report (EPAR) · European Medicines Agency
Need Xcopri 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.